Babylon Healthcare targets chronic disease in $100 million expansion

Artificial intelligence company Babylon Health said it would invest $100 million to double its team of engineers and scientists in London and expand its capabilities to manage chronic diseases such as diabetes and depression.

Be the first to comment

Leave a Reply

Your email address will not be published.